Serum keratan sulfate is a promising marker of early articular cartilage breakdown

Rheumatology

Volumn 46, Issue 11, 2007, Pages 1652-1656

  Wakitani, Shigeyuki ^a   Nawata, M ^b   Kawaguchi, A ^a   Okabe, T ^c   Takaoka, K ^a   Tsuchiya, T ^d   Nakaoka, R ^d   Masuda, H ^e   Miyazaki, K ^e  

^a School of Medicine   (Japan)

^b Marunouchi Hospital   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e Seikagaku Corporation   (United States)

Author keywords

Cartilage injury; Cartilage oligomeric protein; Glycosaminoglycan; Keratan sulfate; Osteoarthritis; Serum marker

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; CHONDROITIN 6 SULFATE; HYALURONIC ACID; KERATAN SULFATE;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BLOOD LEVEL; CHONDROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KNEE ARTHROSCOPY; KNEE INJURY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ARTHROSCOPY; BIOLOGICAL MARKERS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; KERATAN SULFATE; KNEE INJURIES; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

EID: 35548996800     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem220     Document Type: Article

References (20)

1. Aroen A, Loken S, Heir S et al. Articular cartilage lesions in 993 consecutive knee arthroscopies. Am J Sports Med 2004;32:211-5.
2. Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poshling GG. Cartilage injuries: A review of 31,516 knee arthroscoples. Arthroscopy 1997;13:456-460.
3. Hjelle K, Solheim E, Strand T, Muri R, Brittberg M. Articular cartilage defects in 1,000 knee arthroscopies. Arthrosoopy 2002;18:730-4.
4. Messner K, Maletius W. The long-term prognosis for severe damage to weight-beading cartilage in the knee: A 14-year clinical and radiographic follow-up in 28 young athletes. Acta Orthop Scand 1996;67:165-8.
5. Shelbourne KD, Jari S, Gray T. Outcome of unreated traumatic articular cartilage defects of the knee: A natural history study. J Bone Joint Surg Am 2003;85-A (Suppl 2);8-16.
6. Thonar EJ, Lenz ME, Klintworth GK et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-76.
7. Campion GV, McCree F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
8. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997;56:299-W7.
9. Mundermann A, Dyrby CO, Andriacchi TP, King KB. Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults. Osteoarthr Cartilage 2005;13:34-8.
10. Bruyere O, Collette J, Kothari M et al. Ostsoarthritis, magnetic resonance imaging, and biochemical markers: A one year prospective study. Ann Rheum Dis 2006;65:1050-4.
11. Mazzuca SA, Poole AR, Brandt KD et al. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rhematol 2006;33:1147-51.
12. Okumura M, Tagami M, Fujinaga T. Measurement of serum and synovial fluid keratan sulphate and antibody to collagen type II in equine osteoarthritis. J Vet Med A 1998;45:513-6.
13. Tomatsu S, Okamura K, Maeda H et al. Keratan sulphate levels in mucopolysaccharidoses and mucollpidoses. J Inherit Metab Dis 2005;28:187-202.
14. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
15. Ayral X, Altman RD. Arthroscopic evaluation of knee articular cartilage. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Oxford: Oxford University Press, 1998;494-505.
16. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
17. Uesaka S, Nakayama Y, Shirai Y, Yoshihara K. Serum and synovial fluid levels of chondroitin sulfate in patients with osteoarthritis of the knee joint. J Nippon Med Sch 2001;68:165-70.
18. Salisbury C, Sharif M. Relations between synovial fluid and senum concentrations of osteocalcin and other markers of joint tissue tumover in the knee joint compared with peripheral blood. Ann Rheum Dis 1997;58:558-61.
19. Gemero P, Pipermo M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism a patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26.
20. Budsberg SC, Lenz ME, Thonar EJ. Serum and synavial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritie following cranial cruciate ligament transection. Am J Vet Res 2006;67:429-32.